| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/03/2004 | US20040105903 Novel tablets incorporating isoflavone plant extracts and methods of manufacturing water soluble polymer-based rapidly dissolving tablets and production processes thereof |
| 06/03/2004 | US20040105900 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 06/03/2004 | US20040105898 Acidified nitrite as an antimicrobial agent |
| 06/03/2004 | US20040105891 Modafinil formulations |
| 06/03/2004 | US20040105889 comprising nanoparticulate active agents and stabilizers; particularly useful for patients who cannot swallow or who have difficulty swallowing |
| 06/03/2004 | US20040105887 Controlled release oxycodone compositions |
| 06/03/2004 | US20040105886 valproic acid moiety of the divalproex sodium is neutralized by addition of a strong base formulated into stable solid oral dosage forms even in the absence of oligomeric structure and equimolar ratio of sodium valproate and valproic acid |
| 06/03/2004 | US20040105885 Gelatin capsule exhibiting reduced cross-linking |
| 06/03/2004 | US20040105884 sulfites, such as: sodium metabisulfite, sodium bisulfite, and sodium thiosulfate allow capsule to consistently meet desired in vitro dissolution criteria, even after storage under stressed conditions |
| 06/03/2004 | US20040105883 Amines, such as: ethanolamine, ethylenediamine, diethylamine allow capsule to consistently meet desired in vitro dissolution criteria, even after storage under stressed conditions |
| 06/03/2004 | US20040105882 a membrane fusion liposome fused to Sendai virus for use in the treatment for arterial disorders or cartilage injuries |
| 06/03/2004 | US20040105881 Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 06/03/2004 | US20040105878 Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers |
| 06/03/2004 | US20040105874 comprising silicone matrix, a hydrophilic carrier, and at least one active agent comprising proteins, particularly enzymes such as hydrolases and glucose oxidase for enzymatic debridement, clotting formation and clot removal and wound healing |
| 06/03/2004 | US20040105873 ascorbic acid compositions that stabilize unusually large concentrations of vitamin C and vitamin E |
| 06/03/2004 | US20040105850 Administering nitrosated angiotensin converting enzyme inhibitors and other nitrosated compounds for cardiovascular disorders and treatment of hypertensive agents |
| 06/03/2004 | US20040105848 Enteric dialysis to treat renal, kidney and gastrointestinal problems andprobiotic bacteria to reduce urea |
| 06/03/2004 | US20040105835 hydroxpropylated starch (HPS) or hydroxylethylated starch (HES) for the use in pharmaceutical, veterinary, food, cosmetic or other products like films for wrapping food, aspics or jellies, for predosed formulations like soft or hard capsules |
| 06/03/2004 | US20040105834 Hydrogel compositions with an erodible backing member |
| 06/03/2004 | US20040105822 Combinations of formoterol and mometasone furoate for asthma |
| 06/03/2004 | US20040105821 Sustained release pharmaceutical formulation for inhalation |
| 06/03/2004 | US20040105820 Phospholipid-based powders for inhalation |
| 06/03/2004 | US20040105819 Respiratory drug condensation aerosols and methods of making and using them |
| 06/03/2004 | US20040105818 Diuretic aerosols and methods of making and using them |
| 06/03/2004 | US20040105798 Sterilizing tunnel for pharmaceutical containers |
| 06/03/2004 | US20040105778 Gamma irradiation of solid nanoparticulate active agents |
| 06/03/2004 | US20040104142 Blister package for topiramate tablets |
| 06/03/2004 | US20040103902 Condom with an erectogenic composition |
| 06/03/2004 | US20040103821 a basic amino acid a basic phosphate; acid resistance, masking characteristics, moisture resistance, gloss, and stability; no organic solvent required |
| 06/03/2004 | DE20320377U1 Neuer Filmüberzug New film coating |
| 06/03/2004 | DE10253623A1 Bioabbaubare kolloidale Partikel, insbesondere für pulmonale Applikationen Biodegradable colloidal particles, in particular for pulmonary applications |
| 06/03/2004 | DE10252726A1 Mehrschichtiges transmucosales therapeutisches System Multilayer transmucosal therapeutic system |
| 06/03/2004 | DE10252725A1 Feuchtigkeitsaktivierbare Klebstoffe für medizinische Anwendungszwecke Moisture activated adhesives for medical applications |
| 06/03/2004 | DE10133305B4 Ubichinon Konzentrat Ubiquinone concentrate |
| 06/03/2004 | CA2545877A1 Biodegradable colloidal particles for pulmonary applications in particular |
| 06/03/2004 | CA2543393A1 Combination of monounsaturated fatty acids and estrogen, and their use |
| 06/03/2004 | CA2506842A1 Amplification of biotin-mediated targeting |
| 06/03/2004 | CA2506241A1 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 06/03/2004 | CA2505833A1 Edible film for relief of cough or symptoms associated with pharyngitis |
| 06/03/2004 | CA2505486A1 Process to minimize loss through adhesion to equipment surfaces |
| 06/03/2004 | CA2505485A1 Pharmaceutical tablets containing tibolone and a coating |
| 06/03/2004 | CA2502915A1 Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions |
| 06/03/2004 | CA2502025A1 Pharmaceutical compositions having a modified vehicle |
| 06/03/2004 | CA2501978A1 Pharmaceutical composition comprising octreotide microparticles |
| 06/02/2004 | EP1424319A1 Spray-dried xylitol and process for its production |
| 06/02/2004 | EP1424081A1 Polysaccharide-containing compositions and use thereof |
| 06/02/2004 | EP1424080A1 Gnrh agonist combination drugs |
| 06/02/2004 | EP1424077A1 Isulin-containing oral spray and the preparation method thereof |
| 06/02/2004 | EP1424069A2 Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter |
| 06/02/2004 | EP1424068A1 Process for the preparation of pellets comprising a tricyclic or tetracyclic antidepressant and pharmaceutical compositions comprising these pellets |
| 06/02/2004 | EP1424067A1 Injectable foam and novel pharmaceutical applications thereof |
| 06/02/2004 | EP1424066A1 Dry compositions comprising hydrophobic stabilisers |
| 06/02/2004 | EP1424062A1 Screening composition containing at least one dibenzoylmethane derivative and at least one 3-(2-azacycloalkylidene)-1,3-dihydro-indol-2-one; photostabilisation process |
| 06/02/2004 | EP1423413A1 Peptidic compounds selectively binding to p-selectin |
| 06/02/2004 | EP1423412A2 Homing peptides |
| 06/02/2004 | EP1423175A1 Methods for micronization of hydrophobic drugs |
| 06/02/2004 | EP1423161A1 A pellet implant system and method of administration |
| 06/02/2004 | EP1423157A2 Stabilizing catheter for protein drug delivery |
| 06/02/2004 | EP1423154A2 Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments |
| 06/02/2004 | EP1423150A2 Sustained release of microcrystalline peptide suspensions |
| 06/02/2004 | EP1423147A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 06/02/2004 | EP1423142A1 Helicobacter pylori vaccination with a combination of caga, vaca and nap proteins |
| 06/02/2004 | EP1423126A2 Treatment of hyperproliferative conditions of body surfaces |
| 06/02/2004 | EP1423124A2 Lyophilized formulation comprising olanzapine |
| 06/02/2004 | EP1423118A1 Method and composition for treatment of cancer |
| 06/02/2004 | EP1423116A1 Method of treating alcoholism or alcohol abuse |
| 06/02/2004 | EP1423112A1 A combination of quetiapine and zolmitriptan |
| 06/02/2004 | EP1423109A2 Compositions comprising pectin and ascorbic acid |
| 06/02/2004 | EP1423102A1 Plaster for the treatment of dysfunctions and disorders of nail growth |
| 06/02/2004 | EP1423101A1 Plaster for the treatment of dysfunctions and disorders of nails |
| 06/02/2004 | EP1423100A1 Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
| 06/02/2004 | EP1423099A1 A new extended release oral dosage form |
| 06/02/2004 | EP1423098A1 A new extended release oral dosage form |
| 06/02/2004 | EP1423097A1 Controlled release formulation of clarithromycin or tinidazol |
| 06/02/2004 | EP1423096A1 A process for preparing crystalline drug particles by means of precipitation |
| 06/02/2004 | EP1423095A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/02/2004 | EP1423094A2 A new method |
| 06/02/2004 | EP1423092A2 Functional powders for oral delivery |
| 06/02/2004 | EP1423088A2 Stabilisation of oxidation-sensitive and uv-sensitive active ingredients |
| 06/02/2004 | EP1423081A2 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 06/02/2004 | EP1423019A1 Process for preparing concentrate thickener compositions |
| 06/02/2004 | EP1380639A8 Method for producing a water-alcohol solution and products based thereon |
| 06/02/2004 | EP1343455A4 Expanded perborate salt, use, and method of production |
| 06/02/2004 | EP1274405B1 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 06/02/2004 | EP1267832B1 SELF EMULSIFYING DRUG DELIVERY SYSTEM, wherein the fatty agent is optional |
| 06/02/2004 | EP1227824B1 Transplant/implant device and method for its production |
| 06/02/2004 | EP1162626B1 Radioactive microsphere and method for preparation thereof |
| 06/02/2004 | EP1100344B1 Chitosan-containing liquid compositions and methods for their preparation and use |
| 06/02/2004 | EP1098635B1 Enteric coated pharmaceutical tablet containing didanosine |
| 06/02/2004 | EP1056445B1 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent |
| 06/02/2004 | EP1016409B1 Freeze dried composition comprising glycosphingolipids |
| 06/02/2004 | EP1007008B1 Compositions for treating pulmonary disorders using optically pure (s)-salmeterol |
| 06/02/2004 | EP0959874B1 High dose liposomal aerosol formulations |
| 06/02/2004 | EP0948965B1 Stable medicinal compositions containing 4,5-epoxymorphinane derivatives |
| 06/02/2004 | EP0792279B1 Antibiotic cryptdin peptides and methods of their use |
| 06/02/2004 | CN2618595Y Food capsule |
| 06/02/2004 | CN1501909A Novel succinate salt of o-desmethyl-venlafaxine |
| 06/02/2004 | CN1501903A Stable solution of reduced coenzyme q |
| 06/02/2004 | CN1501826A Device for percutaneous transdermal delivery having coated micro-protrusions |
| 06/02/2004 | CN1501814A Pharmaceutical compositions |